A Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic Malignancies-Reference-Cited by-同舟云学术

A Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic Malignancies

Published:2021-10 Issue:10 Volume:27 Page:837.e1-837.e10
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Saber Wael,Steinert Patricia,Zhang Mei-Jie,Chen Min,Pope Andrea,Keating Armand,Wingard John R.,Ballen Karen,Stiff Patrick,Perales Miguel-Angel,Forman Stephen,Champlin Richard,Langston Amelia,Rudebeck Mattias,Horowitz Mary

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference36 articles.

1. Efficacy of palifermin in the hematopoietic stem cell transplant setting;Panjwani;J Adv Pract Oncol,2013

2. Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support;Radtke;J Oncol Pharm Pract,2005

3. The effect of oral mucositis on morbidity and mortality in bone marrow transplant;Gabriel;Semin Oncol,2003

4. Oral complications of cancer and cancer therapy: from cancer treatment to survivorship;Epstein;CA Cancer J Clin,2012

5. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients;Sonis;Cancer,2004

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Possible Drug Repurposing and Accelerated Wound Healing;Regenerative Engineering and Translational Medicine;2024-07-09